VLO
39
-9
LMT
59
4
HSY
43
2
TXT
82
4
AME
72
6
AKAM
64
2
A
43
-5
PVH
32
2
CCL
81
16
IVZ
70
2
ALLE
44
3
IRM
41
10
LOW
43
-6
JBHT
65
2
VZ
35
-2
CHRW
82
3
PSX
37
2
VFC
70
2
MUR
36
3
PNR
51
3
VLO
39
-9
LMT
59
4
HSY
43
2
TXT
82
4
AME
72
6
AKAM
64
2
A
43
-5
PVH
32
2
CCL
81
16
IVZ
70
2
ALLE
44
3
IRM
41
10
LOW
43
-6
JBHT
65
2
VZ
35
-2
CHRW
82
3
PSX
37
2
VFC
70
2
MUR
36
3
PNR
51
3
Financhill
Back

State Street SPDR S&P Biotech ETF Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73

XBI
State Street SPDR S&P Biotech ETF

Last Price:
$123.54
Seasonality Move:
2.94%

7 Day Trial

ALL ACCESS PASS

$ 7

State Street SPDR S&P Biotech ETF Stock Forecast

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 13.6% based on the past 19 years of stock performance.
  • State Street SPDR S&P Biotech ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%
  • Is State Street SPDR S&P Biotech ETF Stock Undervalued?
    The current State Street SPDR S&P Biotech ETF [XBI] share price is $123.43. The Score for XBI is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
  • XBI is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.

Will State Street SPDR S&P Biotech ETF Stock Go Up Next Year?

  • Over the next 52 weeks, State Street SPDR S&P Biotech ETF has on average historically risen by 13.6% based on the past 19 years of stock performance.

State Street SPDR S&P Biotech ETF Stock Rating

Buy
73
State Street SPDR S&P Biotech ETF (XBI) is a Buy

Is State Street SPDR S&P Biotech ETF overpriced?

  • State Street SPDR S&P Biotech ETF has risen higher in 12 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 63.16%

State Street SPDR S&P Biotech ETF Stock Price History

Is XBI stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XBI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
125.87
52-Week Low:
66.66

Prediction Charts

Market Cap:
0
Price in USD:
123.43
Volume:
13M
Beta:
0.96

Technical Analysis

SMA50:
114.84
SMA100:
104.04
SMA200:
93.18
52-Wk Change:
37.43%

Stock Predictions

  • Is State Street SPDR S&P Biotech ETF stock public?
    Yes, State Street SPDR S&P Biotech ETF is a publicly traded company.
  • What is the State Street SPDR S&P Biotech ETF stock quote today?
    The State Street SPDR S&P Biotech ETF stock price is 123.43 USD today.
  • How to buy State Street SPDR S&P Biotech ETF stock online?
    You can buy State Street SPDR S&P Biotech ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 119.80 118.46 120.26 117.72
Dec-3 118.76 121.83 121.96 118.74
Dec-4 121.22 123.25 123.61 120.78
Dec-5 123.77 123.41 124.18 122.69
Dec-8 125.15 123.66 125.87 123.41
Dec-9 123.08 121.19 124.00 121.13
Dec-10 121.23 122.05 122.64 120.66
Dec-11 122.01 123.02 123.75 121.80
Dec-12 123.01 123.13 123.61 121.90
Dec-15 123.41 122.84 124.53 122.22
Dec-16 122.20 122.01 122.82 120.98
Dec-17 122.19 120.94 122.99 120.81
Dec-18 121.11 120.01 122.03 119.59
Dec-19 120.74 123.43 124.03 120.74

State Street SPDR S&P Biotech ETF Earnings

Data Unavailable

State Street SPDR S&P Biotech ETF Forecast Revenue Growth

Data Unavailable

* State Street SPDR S&P Biotech ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.